Bronchogen 20 mg

Technical Details

Dosage & Usage Guidelines

Bronchogen 20 mg is used in experimental protocols investigating:

• Bronchial epithelial regeneration
• Recovery from acute respiratory distress syndrome (ARDS)
• Post-viral lung inflammation
• Asthma and COPD models

Researchers have also studied Bronchogen alongside peptides like BPC-157 and Semax for comprehensive recovery in pulmonary and systemic inflammation models.

Suggested Experimental Use

• Dose: 10–20 mg per day (split or single administration)
• Administration: Subcutaneous or intranasal (depending on delivery study)
• Cycle: 7–21 days in respiratory repair protocols

Stacking Options

Bronchogen is often stacked in research with the following compounds for synergistic outcomes:

• GHK-CU – lung and skin regeneration
• ARA-290 – for inflammation and nerve modulation
• AOD 9604 – metabolic support in post-repair models

Safety Profile

Bronchogen does not impact hormonal levels, is non-toxic to the liver, and does not promote androgenic or estrogenic activity. Side effects in research models are rare and typically limited to mild site irritation or transient fatigue.

Legal Disclaimer

Bronchogen is not approved by the FDA for medical use and is sold exclusively for laboratory and research purposes. It must not be used in humans or animals outside controlled environments. For regulatory updates, visit the ClinicalTrials.gov database.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions